» Articles » PMID: 12805317

Morphine Withdrawal Increases Glutamate Uptake and Surface Expression of Glutamate Transporter GLT1 at Hippocampal Synapses

Overview
Journal J Neurosci
Specialty Neurology
Date 2003 Jun 14
PMID 12805317
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

Opiate abuse causes adaptive changes in several processes of synaptic transmission in which the glutamatergic system appears a critical element involved in opiate tolerance and dependence, but the underlying mechanisms remain unclear. In the present study, we found that glutamate uptake in hippocampal synaptosomes was significantly increased (by 70% in chronic morphine-treated rats) during the morphine withdrawal period, likely attributable to an increase in the number of functional glutamate transporters. Immunoblot analysis showed that expression of GLT1 (glutamate transporter subtype 1) was identified to be upregulated in synaptosomes but not in total tissues, suggesting a redistribution of glutamate transporter expression. Moreover, the increase in glutamate uptake was reproduced in cultured neurons during morphine withdrawal, and the increase of uptake in neurons could be blocked by dihydrokainate, a specific inhibitor of GLT1. Cell surface biotinylation and immunoblot analysis showed that morphine withdrawal produced an increase in GLT1 expression rather than EAAC1 (excitatory amino acids carrier 1), a neuronal subtype, at the cultured neuronal cell surface, whereas no significant change was observed in that of cultured astrocytes. Electron microscopy also revealed that GLT1 expression was markedly increased in the nerve terminals of hippocampus and associated with the plasma membrane in vivo. These results suggest that GLT1 in hippocampal neurons can be induced to translocate to the nerve terminals and express on the cell surface during morphine withdrawal. The translocation of GLT1 at synapses during morphine withdrawal provides a neuronal mechanism for modulation of excitatory neurotransmission during opiate abuse.

Citing Articles

The epigenetic signatures of opioid addiction and physical dependence are prevented by D-cysteine ethyl ester and betaine.

McDonough J, Singhal N, Getsy P, Knies K, Knauss Z, Mueller D Front Pharmacol. 2024; 15:1416701.

PMID: 39281282 PMC: 11392886. DOI: 10.3389/fphar.2024.1416701.


The cell-permeant antioxidant D-thiol ester D-cysteine ethyl ester overcomes physical dependence to morphine in male Sprague Dawley rats.

Getsy P, Coffee G, Bates J, Parran T, Hoffer L, Baby S Front Pharmacol. 2024; 15:1444574.

PMID: 39253377 PMC: 11381264. DOI: 10.3389/fphar.2024.1444574.


Lipophilic analogues of D-cysteine prevent and reverse physical dependence to fentanyl in male rats.

Bates J, Getsy P, Coffee G, Baby S, MacFarlane P, Hsieh Y Front Pharmacol. 2024; 14:1336440.

PMID: 38645835 PMC: 11026688. DOI: 10.3389/fphar.2023.1336440.


L-cysteine ethyl ester prevents and reverses acquired physical dependence on morphine in male Sprague Dawley rats.

Bates J, Getsy P, Coffee G, Baby S, MacFarlane P, Hsieh Y Front Pharmacol. 2023; 14:1303207.

PMID: 38111383 PMC: 10726967. DOI: 10.3389/fphar.2023.1303207.


Amelioration of morphine withdrawal syndrome by systemic and intranasal administration of mesenchymal stem cell-derived secretome in preclinical models of morphine dependence.

Quezada M, Ponce C, Berrios-Carcamo P, Santapau D, Gallardo J, De Gregorio C CNS Neurosci Ther. 2023; 30(4):e14517.

PMID: 37927136 PMC: 11017443. DOI: 10.1111/cns.14517.


References
1.
Robbins T, Everitt B . Drug addiction: bad habits add up. Nature. 1999; 398(6728):567-70. DOI: 10.1038/19208. View

2.
Escriba P, Garcia-Sevilla J . Parallel modulation of receptor for activated C kinase 1 and protein kinase C-alpha and beta isoforms in brains of morphine-treated rats. Br J Pharmacol. 1999; 127(2):343-8. PMC: 1566027. DOI: 10.1038/sj.bjp.0702555. View

3.
Fan G, Wang L, Qiu H, Ma L, Pei G . Inhibition of calcium/calmodulin-dependent protein kinase II in rat hippocampus attenuates morphine tolerance and dependence. Mol Pharmacol. 1999; 56(1):39-45. DOI: 10.1124/mol.56.1.39. View

4.
Manzoni O, Williams J . Presynaptic regulation of glutamate release in the ventral tegmental area during morphine withdrawal. J Neurosci. 1999; 19(15):6629-36. PMC: 6782799. View

5.
Martin G, Ahmed S, Blank T, Spiess J, Koob G, Siggins G . Chronic morphine treatment alters NMDA receptor-mediated synaptic transmission in the nucleus accumbens. J Neurosci. 1999; 19(20):9081-9. PMC: 6782743. View